Page last updated: 2024-09-04

satavaptan and argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-

satavaptan has been researched along with argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)- in 2 studies

Compound Research Comparison

Studies
(satavaptan)
Trials
(satavaptan)
Recent Studies (post-2010)
(satavaptan)
Studies
(argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-)
Trials
(argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-)
Recent Studies (post-2010) (argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-)
9511305500

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C1

Other Studies

2 other study(ies) available for satavaptan and argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-

ArticleYear
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    British journal of pharmacology, 1998, Volume: 125, Issue:7

    Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium

1998
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
    Kidney international, 2000, Volume: 58, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance

2000